These findings indicate that the functions and targets of HDACs are not the same across all breast cancers and can be dependent on the subcellular location of the HDAC, breast cancer subtype, metastatic status, hormone receptor expression, and tumor grade. Here, NR4A1 is linked to breast carcinoma.